| BJDX Stock | | | USD 3.93 0.24 5.76% |
CFO
Frances Scally is Principal CFO of Bluejay Diagnostics
| Age | 57 |
| Address | 360 Massachusetts Avenue, Acton, MA, United States, 01720 |
| Phone | 844 327 7078 |
| Web | https://bluejaydx.com |
Bluejay Diagnostics Management Efficiency
The company has return on total asset
(ROA) of
(0.5851) % which means that it has lost $0.5851 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
(1.2525) %, meaning that it created substantial loss on money invested by shareholders. Bluejay Diagnostics' management efficiency ratios could be used to measure how well Bluejay Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to rise to -1.94 in 2024.
Return On Capital Employed is likely to rise to -3.16 in 2024. At this time, Bluejay Diagnostics'
Total Assets are fairly stable compared to the past year.
Non Currrent Assets Other is likely to rise to about 30.1
K in 2024, whereas
Net Tangible Assets are likely to drop slightly above 6.8
M in 2024.
Bluejay Diagnostics currently holds 352.98
K in liabilities with Debt to Equity
(D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Bluejay Diagnostics has a current ratio of 17.06, suggesting that it is
liquid enough and is able to pay its financial obligations when due. Note, when we think about Bluejay Diagnostics' use of debt, we should always consider it together with its cash and equity.
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts. Bluejay Diagnostics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 9 people. Bluejay Diagnostics (BJDX) is traded on NASDAQ Exchange in USA. It is located in 360 Massachusetts Avenue, Acton, MA, United States, 01720 and employs 10 people. Bluejay Diagnostics is listed under Health Care Equipment & Supplies category by Fama And French industry classification.
Management Performance
Bluejay Diagnostics Leadership Team
Elected by the shareholders, the Bluejay Diagnostics' board of directors comprises two types of representatives: Bluejay Diagnostics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bluejay. The board's role is to monitor Bluejay Diagnostics' management team and ensure that shareholders' interests are well served. Bluejay Diagnostics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bluejay Diagnostics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kenneth CPA, Chief Officer | |
| Kevin Vance, Chief Officer | |
| Jason Cook, Chief Officer | |
| Mark MD, Chief Advisor | |
| Les DeLuca, Vice Operations | |
| Eryn Graham, Marketing Manager | |
| Frances Scally, Principal CFO | |
| Ryan McSeveney, Corporate Controller | |
| Mark Feinberg, Chief Advisor | |
| Indranil Dey, Accounting Financial | |
Bluejay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bluejay Diagnostics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Bluejay Stock Analysis
When running Bluejay Diagnostics' price analysis, check to
measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to
predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.